Weekly dealmaking roundup in charts

28 November, 2016

In the deals space, Gurgaon-based cloud telephony firm Knowlarity raised $20 million in a Series C round with equity and debt components from Delta Partners, Mayfield Fund and others.

The week also saw real estate portal Housing.com get $5 million in a bridge round of funding from its lead investor Japan’s Softbank group.

In the M&A space, Sun Pharma acquired an 85.1% stake in Russian pharmaceutical company Biosintez for $60 million. In an another deal involving a pharma company, Cipla made an exit from its 16.7% stake in US-based Chase Pharmaceuticals following its acquisition by a subsidiary of Allergan Plc.

Also, Subash Chandra’s Essel Group acquired the radio and television broadcasting businesses of Anil Ambani’s Reliance Broadcast Network. The M&A activity in startup space have seen online classifieds firm Quikr India acquiring Bengaluru-based online rental platform Grabhouse.com and Chennai-based online pharmacy Netmeds.com buying Gurgaon’s hyperlocal drug delivery app Pluss.

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Actis elicits interest from investors for stake in Symbiotec Pharmalab

Actis elicits interest from investors for stake in Symbiotec Pharmalab

Ranjani Raghavan 11 months ago
Private equity firm Actis Capital, which invested in Symbiotec Pharmalab in October 2013, has received interest from investors for its stake in the Indore-based drugmaker,...
FIPB clears Fosun-Gland Pharma deal

FIPB clears Fosun-Gland Pharma deal

Ranjani Raghavan 5 months ago
Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from Foreign Investment Promotion Board (FIPB) to pick up a majority stake in Hyderabad-based Gland Pharma...
Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Ranjani Raghavan 4 months ago
Private equity (PE) firm Actis Advisers Pvt. Ltd. has engaged an investment bank for the sale of its majority stake in Symbiotec Pharmalab Pvt. Ltd...
No Comments

Weekly dealmaking roundup in charts

Powered by WordPress.com VIP